Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)

NCT00957957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2016-01-20

No results posted yet for this study

Summary

This study will examine changes in various gut-derived hormones in obese type 2 diabetic patients before and after elective bariatric surgery.

Conditions

  • Obesity, Morbid
  • Diabetes Mellitus Type 2

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2014-11-30
Completion
2014-11-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00957957 on ClinicalTrials.gov